Massachusetts General Hospital

Biography

Dr. Parks is a graduate of Kansas City University of Medicine and Biosciences and completed her residency and fellowship through Robert Wood Johnson Medical School. She completed subspecialty training in advanced heart failure and cardiac transplantation at Massachusetts General Hospital where she currently practices with a focus on clinical care. She is an instructor in medicine at Harvard Medical School and is actively involved in teaching residents, fellows and medical students.

She has been an active participant in medical organizations, previously serving on the governing council of the American Medical Association. She has received awards in teaching and for her leadership and has lectured nationally and internationally on heart failure and cardiac transplantation. Her interests are focused on clinical care of patients with heart failure and she is involved in numerous clinical research studies on cardiac resynchronization therapy and implantable monitoring for heart failure. She developed the Heart Failure Device Monitoring Clinic, designed to provide intensive monitoring for patients with heart failure and prevent hospitalization for decompensated heart failure.

She volunteers her time to medical missions with an organization by the name of International Health Care Volunteers, an organization that provides free health care to people in underserved countries. She is currently writing a non-fiction novel about her inspirational and interpersonal experiences with patients and the physician/patient relationship.

ResearchClinical research focus is on investigational devices for heart failure including cardiac resynchronization therapy, remote monitoring of heart failure, implantable monitoring devices via direct and indirect left atrial pressure monitoring and technologies aimed at reducing heart failure hospitalizations and improving morbidity. Current multi center device trials open to enrollment:

• CLEPSYDRA
• ECHO-CRT
• Z-LAP
• DIRECT
• Upcoming Trials:
• LAPTOP-HF 

Publications

Parks K, Fatima U, Gnana H, Parrillo J, Engel T. Chest, 2004; 126(4): 827S

Verma V, Parks K, Iliadis L. The utility of Technitium-99m Myocardial Perfusion imaging After Transmyocardial Laser Revascularization Chest, 2004; 126(4): 710S

Parks K, Gonczarek K, Moukarbel G, Onuma O, Rosengard B, Semigran MJ, Carlson W, Short term outcomes following induction therapy using CD3 guided low dose anti thymocyte globulin post cardiac transplantatio? J Heart Lung Transplant, 2009; 28(2) S1: S91

Parks K, Semigran MJ, Stone JR, "Myocardial Upregulation of hnRNP-C Predicts Short Term Recovery in Patients with Acute Systolic Heart Failure." Journal of cardiac failure, 2009; 15(6): S41

A heartwarming wedding on Ellison 10

MGH Hotline 1.15.10 It's not often one encounters a touching love story within the four walls of the hospital.

Kim Parks, DO, answers some questions about "Boston Med."

Q&A with Kim Parks, DO, a transplant cardiologist

Chatting with Kimberly Parks, DO, of “Boston Med”

MGH Hotline 08.06.10 Kimberly Parks, DO, a transplant cardiologist at the Massachusetts General Hospital Heart Center, is one of several physicians featured in "Boston Med."

Are caffeine inhalers safe?

Kimberly A. Parks, DO, FACC, cardiologist at Massachusetts General Hospital and James Mojica, MD, associate program director of the Harvard Pulmonary Critical Care Medicine Fellowship Training Program discuss the safety of caffeine inhalers

Treating Heart Failure in the 21st Century

February is American Heart Month, and the spotlight is on heart health. Throughout this month, we will be featuring articles including discussions with physicians in the Massachusetts General Heart Center to learn more about the topics surrounding heart disease, the leading cause of death in the U.S. for both men and women.

Mass. General Patient First in New England to Receive Nerve Stimulator to Treat Heart Failure

Anita Levy, 59, arrived at Massachusetts General Hospital in 2012 with severe heart failure. The mother of four, grandmother of eight and wife of 38 years, was starting to lose hope. After trying a number of therapies without success, her doctors informed her she was a candidate for a new clinical trial.